A new method for analysis of non‐pregnant uterine peristalsis using transvaginal ultrasound

D. Meirzon, Ariel J. Jaffa, Zoya Gordon, David Elad
In: Ultrasound in Obstetrics & Gynecology · 2011 · vol. 38(2) , pp. 217–224 · doi:10.1002/uog.8950 · PMID:21308836 · W2031891278
article OA: bronze CC0 ⤵ 9 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study developed a computerized transvaginal ultrasound method to analyze non-pregnant uterine peristalsis, determining dominant frequencies and maximal amplitudes of endometrial-myometrial and fluid-endometrial interfaces.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: To develop an objective method for analysis of uterine peristalsis using transvaginal sonography (TVS). METHODS: We performed computerized analysis of 2-5-min video recordings of TVS imaging of a midsagittal cross-section of the uterus during the proliferative and early secretory phases of 18 healthy volunteers aged 28-41 years. The contours of the fluid-endometrial interface (FEI) and the endometrium-myometrium interface (EMI) were detected in each frame, and the data from all frames were used to explore the dynamic motility characteristics of these interfaces at fixed distances from the fundus. RESULTS: The mean ± SD dominant frequency of peristalsis of the EMI along the midsagittal cross-section was 0.049 ± 0.01 Hz and that of the cavity center was 0.043 ± 0.02 Hz. The maximal amplitudes of the EMI were about 1 ± 0.25 mm, located between 7 and 17 mm from the fundus. The amplitudes of the FEI were in the range 0.05-0.2 mm. The amplitude of the cavity centerline movement was 0.94 ± 0.34 mm, located at the extremes of the unperturbed curve. CONCLUSIONS: This study provides a simple tool for analysis of uterine peristalsis characteristics using ultrasound data. This is possible at the EMI even when the FEI is invisible or incomplete, such as during the luteal phase, when an intrauterine contraceptive device is in place, and during diagnostic or medical intervention.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Cited by (9)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK